NEWS

Daniel Tsay 9/16/24 Daniel Tsay 9/16/24

Piccolo Medical, Inc. Receives FDA Clearance for ECGuide™ Catheter Guidance Technology

Daniel Tsay 1/4/24 Daniel Tsay 1/4/24

Piccolo Medical, Inc. awarded a Commercialization Readiness Pilot (CRP) Program grant from the National Institute of Health

Daniel Tsay 10/2/23 Daniel Tsay 10/2/23

Piccolo Medical, Inc. announces closing of $5.5M Series B Financing to further develop their platform catheter navigation technology

Piccolo Medical, Inc. (Piccolo) today announced the close of a $5.5M Series B financing led by Event Capital Strategies, a medical technology-focused investment fund based in New York. Funding from the Series B will support the further development and commercialization of the Company's catheter guidance technology, including the next-generation SmartPICC® cathether tip location and navigation system that received 510(k) approval from the FDA in January 2021.

Daniel Tsay 6/24/21 Daniel Tsay 6/24/21

Piccolo Medical Appoints Mark Spector, Ph.D. As New CEO

Piccolo Medical announces today that Mark Spector, Ph.D. has been appointed new CEO of the company. An experienced business leader, Mark will succeed Alexey Salamini and assume responsibilities effective immediately.

Daniel Tsay 2/22/21 Daniel Tsay 2/22/21

Piccolo Medical Receives U.S. FDA Clearance of its SmartPICC™ System for the positioning of Peripherally Inserted Central Catheters

Piccolo Medical, Inc. announces that it has received FDA clearance of its SmartPICC™ System.